Trial | NCT02061475  Report issue

Title

Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation
The Efficacy and Safety of Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation Before Surgery: a Multicenter, Randomized, Double -Blind, Placebo-controled and Parallel-group Designed Clinical Trail

  • Phase

    Phase 2/Phase 3

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    lidocaine ...

  • Study Participants

    240
Venipuncture and intravenous cannulation are the most common painful procedures, especially for the penitents who must receive large diameter venous catheter before surgery. In present study we would evaluate the safety and validity of lidocaine patches releasing such pain.
Study Started
Apr 30
2014
Primary Completion
Mar 31
2015
Anticipated
Study Completion
Mar 31
2015
Anticipated
Last Update
Aug 29
2014
Estimate

Drug Lidocaine Patches

Lidocaine Patches Active Comparator

Placebo Patches Placebo Comparator

Criteria 

Inclusion Criteria:

Patients who want to participate present study and sign the informed consent form
Age from 18 to 65 years old
Patients who need intravenous cannulation before surgery
ASA class I-II and selected patients

Exclusion Criteria:

Allergic to lidocaine or any other amide local anesthetics or any other medicine
Allergic skin(allergic to past agent or other topical used medicine)
Skin injured or inflection exist in the local site to patch
Sensation disturbed in any limb
Severe liver and kidney original disease:blood Aspertate aminotransferase and Alanine transaminase increased 1.5 times more than normal concentration; blood creatinine is higher than the normal range.
Hemoglobin <80g/L
ECG is significantly abnormal
pregnant or possible pregnant or breastfeeding woman
Patient who has consciousness disturbance can not make credible dialog with investigator.
Those who are using other medicine may affect the evaluation of present patch
Those who have participated in other clinical trail in the past three months
Those excluded by investigator believed other reasons.
No Results Posted